SK
Suresh Kumar
About Suresh Kumar
Data last updated:
Suresh Kumar is a Director at Eviza Biotech Private Limited (since 2014) and Director at Zavik Drugs Private Limited (since 2011). The companies operate in Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹4.33 Cr; the largest is Eviza Biotech Private Limited at ₹2.51 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eviza Biotech Private Limited U24232CH2014PTC034940 | Director | 28 Jan 2014 | 2014 | ₹2.51 Cr (FY 2025) | Active |
 Zavik Drugs Private Limited U24232CH2011PTC033451 | Director | 30 Dec 2011 | 2011 | ₹1.81 Cr (FY 2025) | Active |
Board colleagues of Suresh Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rohit Kumar | 06779025 | Eviza Biotech Private Limited | Director |
| Ankit Mittal | 05158299 | Zavik Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Kumar
Suresh Kumar currently holds 2 directorships: Eviza Biotech Private Limited (Director, since 28 Jan 2014, revenue ₹2.51 Cr (FY 2025)); Zavik Drugs Private Limited (Director, since 30 Dec 2011, revenue ₹1.81 Cr (FY 2025)).
Suresh Kumar was first appointed on 30 Dec 2011 as Director at Zavik Drugs Private Limited. The most recent appointment on record is 28 Jan 2014 at Eviza Biotech Private Limited.
The 2 current companies of Suresh Kumar that report revenue have a combined latest revenue of ₹4.33 Cr: Eviza Biotech Private Limited ₹2.51 Cr (FY 2025); Zavik Drugs Private Limited ₹1.81 Cr (FY 2025).
The current boards of Suresh Kumar's companies include Rohit Kumar (Eviza Biotech Private Limited), Ankit Mittal (Zavik Drugs Private Limited).